Magenta Medical, Developer of World’s Smallest Heart Pump, Closes $105M Financing Round
DAIC
JULY 29, 2024
It encompasses devices designed to mechanically unload the failing heart and augment cardiac output in the setting of dangerously low blood pressure, providing a bridge to recovery over a period of hours to days. FDA for two clinical indications: high-risk percutaneous coronary intervention (HR-PCI) and cardiogenic shock (CS).
Let's personalize your content